Literature DB >> 18426494

Endocannabinoids and the brain immune system: new neurones at the horizon?

S A Wolf1, O Ullrich.   

Abstract

Whereas, in most brain compartments, neuronal cell renewal during early life is replaced by synaptic plasticity and the potentiation of existing pathways and connections, neurogenesis in the hippocampus occurs throughout adulthood. Neuronal progenitor cells in the dentate gyrus of the hippocampus are thought to be the gatekeepers of memory. Neural progenitor cell proliferation and differentiation depends on their intrinsic properties and local environment and is down-regulated in conditions associated with brain inflammation. Conversely, newly-formed neurones can survive despite chronic inflammation and, moreover, specifically arise within an inflammatory environment. Since the endocannabinoid system controls immune responses via multiple cellular and molecular targets and influences cell proliferation, fate decision and cell survival in the central nervous system, we summarise how neurogenesis might be regulated by brain cannabinoids, either directly or indirectly via the immune system. This review presents clear evidence that the cannabinoid system influences adult neurogenesis. However, there is considerable variability with regard to the strain, model and methods utilised and therefore it is difficult to compare studies investigating the cannabinoid system. As a result, it remains far from clear exactly how endocannabinoids regulate neurogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18426494     DOI: 10.1111/j.1365-2826.2008.01672.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  6 in total

Review 1.  The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research.

Authors:  Sang-Ho Choi; Saba Aid; Francesca Bosetti
Journal:  Trends Pharmacol Sci       Date:  2009-03-09       Impact factor: 14.819

2.  Anti-inflammatory cannabinoids in diet: Towards a better understanding of CB(2) receptor action?

Authors:  Jürg Gertsch
Journal:  Commun Integr Biol       Date:  2008

3.  Cannabinoid Receptor 2 Modulates Susceptibility to Experimental Cerebral Malaria through a CCL17-dependent Mechanism.

Authors:  Judith Alferink; Sabine Specht; Hannah Arends; Beatrix Schumak; Kim Schmidt; Christina Ruland; Ramona Lundt; Andrea Kemter; Andrea Dlugos; Janina M Kuepper; Karola Poppensieker; Matthias Findeiss; Önder Albayram; David-M Otte; Janine Marazzi; Jürg Gertsch; Irmgard Förster; Wolfgang Maier; Stefanie Scheu; Achim Hoerauf; Andreas Zimmer
Journal:  J Biol Chem       Date:  2016-07-29       Impact factor: 5.157

4.  Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis.

Authors:  Susanne A Wolf; Anika Bick-Sander; Klaus Fabel; Perla Leal-Galicia; Svantje Tauber; Gerardo Ramirez-Rodriguez; Anke Müller; Andre Melnik; Tim P Waltinger; Oliver Ullrich; Gerd Kempermann
Journal:  Cell Commun Signal       Date:  2010-06-17       Impact factor: 5.712

Review 5.  Brain innate immunity in the regulation of neuroinflammation: therapeutic strategies by modulating CD200-CD200R interaction involve the cannabinoid system.

Authors:  Miriam Hernangómez; Francisco J Carrillo-Salinas; Miriam Mecha; Fernando Correa; Leyre Mestre; Frida Loría; Ana Feliú; Fabian Docagne; Carmen Guaza
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

6.  A preliminary study of the effects of cannabidiol (CBD) on brain structure in patients with epilepsy.

Authors:  Ayushe A Sharma; Rodolphe Nenert; Jane B Allendorfer; Tyler E Gaston; Leslie P Grayson; Kathleen Hernando; Jerzy P Szaflarski
Journal:  Epilepsy Behav Rep       Date:  2019-11-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.